MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jso.70327

Медицинская библиотека · Journal of surgical oncology · 2026

Impact of Revised American Joint Committee on Cancer Staging Guidelines on Upstaging and Treatment of Oral Cavity Squamous Cell Carcinoma.

Kavanagh Fergal G, Eagan Alana, Boe Lillian A, McBride Sean M, Lee Nancy Y, Cohen Marc A, Cracchiolo Jennifer R

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

In 2018, the American Joint Committee on Cancer (AJCC) updated TNM (Tumor, Nodes, Metastasis) staging for oral cavity cancers, incorporating depth of invasion into T-staging, but the impact of this change is unclear. We aimed to assess trends in upstaging and adjuvant radiation therapy use among patients with T1-3 oral cavity tumors using the National Cancer Database (NCDB).

METHODS

NCDB data were analyzed on the staging and treatment of patients with T1-3 histologically confirmed squamous cell carcinoma of the oral cavity treated with surgery from 2013 to 2021. Treatment periods were defined as 2013-2017 and 2018-2021 to reflect use of the 7th and 8th editions of the AJCC staging system. Trends were analyzed using Cochran-Armitage tests, univariable/multivariable logistic regression, and Kaplan-Meier survival plots, and adjusted for sociodemographic, tumor, and hospital variables when relevant. The primary outcome was treatment modality (surgery alone vs. surgery with adjuvant therapy). The secondary outcome was change in tumor staging following the AJCC revision.

RESULTS

We analyzed NCDB data on the staging and treatment of 17,349 patients. The proportion of patients with pathological T1 tumors dropped from 42% to 29% between 2013 and 2017 and 2018-2021, while T3 cases rose from 5.5% to 15% (p < 0.001). The proportion of stage I tumors decreased from 26% to 17%, and stage III tumors increased from 10% to 15% (p < 0.001). Tumor size remained relatively stable. The proportion of patients treated with surgery and adjuvant radiation therapy increased from 29% to 34% (p < 0.001). The increased use of adjuvant radiation after the AJCC revision was confirmed by the Cochran-Armitage test and by multivariable logistic regression, which showed that patients diagnosed in 2018-2021 had higher odds of receiving radiation therapy (odds ratio, 1.33; p < 0.001) than those diagnosed in 2013-2017, after adjustment for covariates. Forty-eight-month overall survival did not differ between cohorts (64% in both groups).

CONCLUSION

Although the 2018 AJCC revision for oral cavity cancer staging led to significant upstaging and increased use of adjuvant radiation therapy, overall survival remained unchanged. The benefits of increased adjuvant therapy use remain unclear and warrant further investigation.

Для цитирования: Kavanagh Fergal G, Eagan Alana, Boe Lillian A, McBride Sean M, Lee Nancy Y, Cohen Marc A, Cracchiolo Jennifer R. Impact of Revised American Joint Committee on Cancer Staging Guidelines on Upstaging and Treatment of Oral Cavity Squamous Cell Carcinoma.. Journal of surgical oncology. 2026. DOI: 10.1002/jso.70327.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.